EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cannabidiol Use in Inflammatory Bowel Disease: Insights From a Gastroenterology Outpatient Population

Karina Fatakhova, Muhammad Jahanzaib Khan, Royce Perera, Sapphire Perera, Benjamin Glazebnik, Lindsey Donnelly, Pratik Patel, Emily Glazer, Greg Haggerty, Hassam Ali iD, Ramona Rajapakse

JGH Open · 2026-04 · 10 (4)

DOI: 10.1002/jgh3.70402 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JGH Open, online erschienen am 07.04.2026. Verfasst von Karina Fatakhova und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology Northwell, Mather Hospital and Zucker School of Medicine at Hofstra University Port Jefferson New York US…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cannabidiol (CBD) is increasingly used for symptom relief in chronic conditions, yet its role in inflammatory bowel disease (IBD) remains underexplored. We surveyed 229 IBD patients and found that 10.5% used CBD, primarily for anxiety (54.2%), insomnia (41.7%), and pain (41.7%). Among users, 87.5% perceived benefit. Most users were female, and one‐third were on biologics. These findings highlight the growing interest in alternative therapies and the need for further research on CBD's safety, efficacy, and clinical guidance in IBD care.

Schlagwörter

Stichwörter der Autor:innen

Cannabidiolcomplementary therapiesinflammatory bowel diseasespatient reported outcomessurveys and questionnaires

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology Northwell, Mather Hospital and Zucker School of Medicine at Hofstra University Port Jefferson New York USA.
  • Cornell University Ithaca New York USA.
  • New York University New York New York USA.
  • Vassar College Poughkeepsie New York USA.
  • Division of Gastroenterology and Hepatology University of South Florida Tampa Florida USA.
  • Division of Gastroenterology and Hepatology East Carolina University Greenville North Carolina USA.

ORCID-Profile: Hassam Ali

Zitieren

APA

Fatakhova, K., Khan, M. J., Perera, R., Perera, S., Glazebnik, B., Donnelly, L., Patel, P., Glazer, E., Haggerty, G., Ali, H., & Rajapakse, R. (2026). Cannabidiol Use in Inflammatory Bowel Disease: Insights From a Gastroenterology Outpatient Population. JGH Open, 10(4). https://doi.org/10.1002/jgh3.70402

Vancouver

Fatakhova K, Khan MJ, Perera R, Perera S, Glazebnik B, Donnelly L, et al. Cannabidiol Use in Inflammatory Bowel Disease: Insights From a Gastroenterology Outpatient Population. JGH Open. 2026;10(4). doi:10.1002/jgh3.70402

BibTeX
@article{Fatakhova2026,
  author = {Fatakhova, Karina and Khan, Muhammad Jahanzaib and Perera, Royce and Perera, Sapphire and Glazebnik, Benjamin and Donnelly, Lindsey and Patel, Pratik and Glazer, Emily and Haggerty, Greg and Ali, Hassam and Rajapakse, Ramona},
  title = {Cannabidiol Use in Inflammatory Bowel Disease: Insights From a Gastroenterology Outpatient Population},
  journal = {JGH Open},
  year = {2026},
  volume = {10},
  number = {4},
  doi = {10.1002/jgh3.70402}
}
Kostenlos starten →